Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
OMGAOmega Therapeutics(OMGA) Zacks Investment Research·2024-05-06 21:11

Omega Therapeutics, Inc. (OMGA) came out with a quarterly loss of 0.36pershareversustheZacksConsensusEstimateofalossof0.36 per share versus the Zacks Consensus Estimate of a loss of 0.38. This compares to loss of 0.50pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof5.260.50 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5.26%. A quarter ago, it was expected that this company would post a loss of 0.46 per share when it actually produced a loss of $0.37, delivering a surprise of 19.57%. Over the last four quarters, the company ha ...